Puig reported a 5.6% increase in third-quarter sales, bolstered by strong results in the Asia-Pacific region. The company is now aggressively expanding its medical-grade skincare presence to balance a slight decline in premium beauty.
Charlotte Tilbury drives a 16.1% surge in makeup sales
The makeup segment, anchored by the powerhouse brand Charlotte Tilbury, grew 16.1% to reach €269.7 million in the third quarter. According to the report, this growth highlights a strong consumer appetite for high-performance makeup that blends luuxry with social-media-driven trends.
This surge reflects a broader shift in internet culture where "glowy" and "sculpted" aesthetics, heavily promoted on platforms like TikTok, continue to drive sales for brands that offer a curated, professional look. for Pembece readers, this suggests that the influence of beauty creators is translating directly into corporate revenue, cementing Charlotte Tilbury's place as a dominant force in the prestige makeup market.
The ISDIN acquisition and the pivot to medical-grade skincare
Puig is doubling down on clinical beauty,as evidenced by the September 14 announcement that the group will acquire the remaining 50% of the Spanish dermocosmetics brand ISDIN. While general skincare sales slipped 0.8% to €135.3 million, the dermocosmetics category—led by Uriage—delivered double-digit growth.
This strategic move aligns with the rise of the "skin-tellectual" consumer. Today's beauty shoppers are increasingly bypassing traditional luxury creams in favor of photo-protection and photo-aging solutions rooted in medical credibility . By integrating ISDIN fully, Puig is positioning itself to capture the fastest-growing segment of the skincare market, moving away from purely aesthetic luxury toward science-backed efficacy.
Carolina Herrera leads as Jean Paul Gaultier growth normalizes
Fragrance and fashion remain the core of the business, growing 3.9% to €985.8 million, with Carolina Herrera delivering double-digit growth. Meanwhile,CFO Miquel Angel Serra noted that growth for Rabanne and Jean Paul Gaultier is "normalizing" after a period of explosive expansion over the last five years.
To reignite momentum, Puig has launched La Favorite in key European markets, already ranking in the top 15 in France. This focus on niche fragrances and targeted innovation reflects a wider industry trend of "scent-scaping," where consumers seek unique, storytelling fragrances rather than mass-market scents. As reported by the source,the global rollout of La Favorite is expected next year.
Asia-Pacific revenues climb 12.9% to €156.5 million
Geographically,the Asia-Pacific region was the standout performer, with revenues rising 12.9% to hit €156.5 million. this outpaced growth in the Americas (6.2% to €506.7 million) and the EMEA region (3.8% to €727.5 million).
The strong performance in Asia-Pacific suggests a recovery in luxury spending within those markets, providing a critical hedge against slower growth in Europe. This geographic diversification is essential as luxury conglomerates navigate fluctuating economic conditions across different continents.
How Puig compares to LVMH's €2 billion Q3 cosmetics haul
The competitive landscape remains fierce, with LVMH's perfumes and cosmetics division reporting €2 billion in Q3. As Puig prepares to present its future roadmap at its Capital Markets Day on October 28 in Madrid, it faces stiff competition from L'Oréal and Estée Lauder, the latter of which reports its first fiscal quarter on November 2.
Despite the strong numbers, several questions remain. The reporrt does not specify exactly how the full acquisition of ISDIN will impact Puig's debt levels or profit margins in the short term. Furthermore, while the group is "betting on skincare," it remains to be seen if the double-digit growth in dermocosmetics can fully offset the softness seen in the premium skincare sector.
Comments 0